Gene expression patterns in glucose-stimulated podocytes

Biochemical and Biophysical Research Communications

Volumn 370, Issue 3, 2008, Pages 514-518

  Han, Seung Hyeok ^a   Yang, Sanghwa ^a   Jung, Dong Sub ^b   Li, Jin Ji ^c   Kim, Jin Ju ^b   Kwak, Seung Jae ^b   Kim, Dong Ki ^a   Moon, Sung Jin ^a   Lee, Jung Eun ^a   Han, Dae Suk ^a   Kang, Shin Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Department of Internal Medicine   (China)

Author keywords

Diabetic nephropathy; Gene expression; Podocyte

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; GLUCOSE; HEME OXYGENASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THROMBOSPONDIN 1; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA MICROARRAY; GENE EXPRESSION PROFILING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLUCOSE; MICE; PODOCYTES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 42749094715     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.03.121     Document Type: Article

References (28)

1. Shankland S.J. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 69 (2006) 2131-2147
2. Wilson K.H., Eckenrode S.E., Li Q.Z., Ruan Q.G., Yang P., Shi J.D., Davoodi-Semiromi A., McIndoe R.A., Croker B.P., and She J.X. Microarray analysis of gene expression in the kidneys of new- and post-onset diabetic NOD mice. Diabetes 52 (2003) 2151-2159
3. Susztak K., Bottinger E., Novetsky A., Liang D., Zhu Y., Ciccone E., Wu D., Dunn S., McCue P., and Sharma K. Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes 53 (2004) 784-794
4. Morrison J., Knoll K., Hessner M.J., and Liang M. Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational response. Physiol. Genomics 17 (2004) 271-282
5. Mundel P., Reiser J., Zuniga Mejia Borja A., Pavenstadt H., Davidson G.R., Kriz W., and Zeller R. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 236 (1997) 248-258
6. Kang S.W., Natarajan R., Shahed A., Nast C.C., LaPage J., Mundel P., Kashtan C., and Adler S.G. Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen alpha5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes. J. Am. Soc. Nephrol. 14 (2003) 3178-3187
7. Ernst J., and Bar-Joseph Z. STEM: a tool for the analysis of short time series gene expression data. BMC Bioinformatics 7 (2006) 191
8. Susztak K., Raff A.C., Schiffer M., and Bottinger E.P. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55 (2006) 225-233
9. Nath K.A. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues. Kidney Int. 70 (2006) 432-443
10. Abraham N.G., Rezzani R., Rodella L., Kruger A., Taller D., Li Volti G., Goodman A.I., and Kappas A. Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H2468-H2477
11. Hayashi K., Haneda M., Koya D., Maeda S., Isshiki K., and Kikkawa R. Enhancement of glomerular heme oxygenase-1 expression in diabetic rats. Diabetes Res. Clin. Pract. 52 (2001) 85-96
12. Wolf G., Butzmann U., and Wenzel U.O. The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol. 93 (2003) P3-P13
13. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R.E., and Acton S. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ. Res. 87 (2000) E1-E9
14. Ye M., Wysocki J., William J., Soler M.J., Cokic I., and Batlle D. Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes. J. Am. Soc. Nephrol. 17 (2006) 3067-3075
15. Simon M., Grone H.J., Johren O., Kullmer J., Plate K.H., Risau W., and Fuchs E. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. Am. J. Physiol. 268 (1995) F240-F250
16. Satchell S.C., Tasman C.H., Singh A., Ni L., Geelen J., von Ruhland C.J., O'Hare M.J., Saleem M.A., van den Heuvel L.P., and Mathieson P.W. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int. 69 (2006) 1633-1640
17. Schrijvers B.F., Flyvbjerg A., and De Vriese A.S. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 65 (2004) 2003-2017
18. Iglesias-de la Cruz M.C., Ziyadeh F.N., Isono M., Kouahou M., Han D.C., Kalluri R., Mundel P., and Chen S. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes. Kidney Int. 62 (2002) 901-913
19. Baelde H.J., Eikmans M., Doran P.P., Lappin D.W., de Heer E., and Bruijn J.A. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am. J. Kidney Dis. 43 (2004) 636-650
20. Buckingham R.E., Al-Barazanji K.A., Toseland C.D., Slaughter M., Connor S.C., West A., Bond B., Turner N.C., and Clapham J.C. Peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats. Diabetes 47 (1998) 1326-1334
21. Yang H.C., Ma L.J., Ma J., and Fogo A.B. Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis. Kidney Int. 69 (2006) 1756-1764
22. Benigni A., Zoja C., Tomasoni S., Campana M., Corna D., Zanchi C., Gagliardini E., Garofano E., Rottoli D., Ito T., and Remuzzi G. Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-gamma agonist: molecular mechanism of the antiproteinuric effect of pioglitazone. J. Am. Soc. Nephrol. 17 (2006) 1624-1632
23. Okada T., Wada J., Hida K., Eguchi J., Hashimoto I., Baba M., Yasuhara A., Shikata K., and Makino H. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms. Diabetes 55 (2006) 1666-1677
24. Guo N., Krutzsch H.C., Inman J.K., and Roberts D.D. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res. 57 (1997) 1735-1742
25. Yevdokimova N., Wahab N.A., and Mason R.M. Thrombospondin-1 is the key activator of TGF-beta1 in human mesangial cells exposed to high glucose. J. Am. Soc. Nephrol. 12 (2001) 703-712
26. Kim J.H., Kim B.K., Moon K.C., Hong H.K., and Lee H.S. Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis. Kidney Int. 64 (2003) 1715-1721
27. Clarkson M.R., Murphy M., Gupta S., Lambe T., Mackenzie H.S., Godson C., Martin F., and Brady H.R. High glucose-altered gene expression in mesangial cells. Actin-regulatory protein gene expression is triggered by oxidative stress and cytoskeletal disassembly. J. Biol. Chem. 277 (2002) 9707-9712
28. Sango K., Suzuki T., Yanagisawa H., Takaku S., Hirooka H., Tamura M., and Watabe K. High glucose-induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32. J. Neurochem. 98 (2006) 446-458